Clinical Trials Browser

Phase 2 × EBV Lymphomas × Lymphoid × Clear all

NCT03988582 2020-06-11

Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies

Phase 2 Withdrawn

EBV Lymphomas

NCT00917826 2011-08-01

Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

Phase 2 Terminated

EBV Lymphomas